|
NRSN Neurosense Therapeutics Ltd 1875091 |
| Balance Sheet |
|
Current Assets
|
1,619,000 |
|
Assets
|
1,841,000 |
|
Current Liabilities
|
3,508,000 |
|
Liabilities
|
3,544,000 |
|
Equity
|
-1,703,000 |
|
Shares Out
|
19,471,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-5,750,000 |
|
Investing Cash Flow
|
1,000 |
| Market Analysis |
Market Cap
|
26,052,199 |
|
Price
|
1.09 |
|
BVPS
|
0.94 |
|
PB
|
1.17 |
|
EPS
|
-0.73 |
|
PS
|
0.65 |
|
FCF
|
-5,749,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NRSN documents filed with the SEC.
NRSN Filings
Clear
